Cited by 1,841Frailty in Older AdultsNutrition and Health in AgingPharmaceutical Practices and Patient Outcomes

The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.

Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study

Open access

Hurria, Arti, Togawa, Kayo, Mohile, Supriya G., Owusu, Cynthia, Klepin, Heidi D., Gross, Cary P., Lichtman, Stuart M., Gajra, Ajeet, Bhatia, Smita, Katheria, Vani, Klapper, Shira, Hansen, Kurt, Ramani, Rupal, Lachs, Mark, Wong, F. Lennie, Tew, William P.·2011·Journal of Clinical Oncology

DOI 10.1200/jco.2011.34.7625PMC PMC3624700

Open this paper in CoChat — free account Open PDF

Abstract

Purpose: Older adults are vulnerable to chemotherapy toxicity; however, there are limited data to identify those at risk. The goals of this study are to identify risk factors for chemotherapy toxicity in older adults and develop a risk stratification schema for chemotherapy toxicity. Patients and Methods: Patients age ≥ 65 years with cancer from seven institutions completed a prechemotherapy assessment that captured sociodemographics, tumor/treatment variables, laboratory test results, and geriatric assessment variables (function, comorbidity, cognition, psychological state, social activity/support, and nutritional status). Patients were followed through the chemotherapy course to capture grade 3 (severe), grade 4 (life-threatening or disabling), and grade 5 (death) as defined by the National Cancer Institute Common Terminology Criteria for Adverse Events. Results: In total, 500 patients with a mean age of 73 years (range, 65 to 91 years) with stage I to IV lung (29%), GI (27%), gynecologic (17%), breast (11%), genitourinary (10%), or other (6%) cancer joined this prospective study. Grade 3 to 5 toxicity occurred in 53% of the patients (39% grade 3, 12% grade 4, 2% grade 5). A predictive model for grade 3 to 5 toxicity was developed that consisted of geriatric assessment variables, laboratory test values, and patient, tumor, and treatment characteristics. A scoring system in which the median risk score was 7 (range, 0 to 19) and risk stratification schema (risk score: percent incidence of grade 3 to 5 toxicity) identified older adults at low (0 to 5 points; 30%), intermediate (6 to 9 points; 52%), or high risk (10 to 19 points; 83%) of chemotherapy toxicity (P < .001). Conclusion: A risk stratification schema can establish the risk of chemotherapy toxicity in older adults. Geriatric assessment variables independently predicted the risk of toxicity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1200/jco.2011.34.7625

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Applied logistic regression
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
The Elements of Statistical Learning
Hastie, T., Tibshirani, R., & Friedman, J. (2009) · Springer Series in Statistics · doi:10.1007/978-0-387-84858-7 · Cited by 25,970
Applied Logistic Regression
Hosmer, D. W., & Lemeshow, S. (2000) · doi:10.1002/0471722146 · Cited by 20,302
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000180580 · Cited by 15,291
A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons
Podsiadlo, D., & Richardson, S. (1991) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1991.tb01616.x · Cited by 14,418
The MOS social support survey
Sherbourne, C. D., & Stewart, A. L. (1991) · Social Science & Medicine · doi:10.1016/0277-9536(91)90150-b · Cited by 6,643
The clinical evaluation of chemotherapeutic agents in cancer
Karnofsky, D. A. (1949) · Medical Entomology and Zoology · Cited by 2,933
Measuring Functioning and Well-Being: The Medical Outcomes Study Approach
Stewart, A., & Ware, J. (1992) · doi:10.7249/cb361 · Cited by 2,689

Show all 43 references

Sorted by citations

Items 801–900 of 1,000

Geriatric Assessment in Colorectal Surgery: A Systematic Review
Cauley, C. E., Samost, A., Philpotts, L. L., Brindle, M. E., Cooper, Z. R., & Ritchie, C. S. (2024) · Journal of Surgical Research · doi:10.1016/j.jss.2023.12.055 · Cited by 12
Aging precisely: Precision medicine through the lens of an older adult
Austin, C. A., Seligman, B. J., Shan‐Bala, S., Kuchel, G. A., Loh, K. P., Kistler, C. E., & Batsis, J. A. (2024) · Journal of the American Geriatrics Society · doi:10.1111/jgs.19036 · Cited by 12
Improving Care for Older Adults with Cancer in Canada: A Call to Action
Cook, S., Alibhai, S. M. H., Mehta, R., Savard, M.-F., Mariano, C. J., Leblanc, D., Desautels, D. N., Pezo, R. C., Zhu, X., Gelmon, K. A., et al. (2024) · Current Oncology · doi:10.3390/curroncol31070279 · Cited by 13
UK national observational cohort study investigating Tolerance of Anti-cancer Systemic Therapy in the Elderly: the TOASTIE study
Baxter, M. A., Rowe, M., Zucker, K., Peters, A., Rohan, M., Marsh, A., Gee, A. L., Quesne, G., Heseltine, J., Prichard, R., et al. (2024) · BMJ Oncology · doi:10.1136/bmjonc-2024-000459 · Cited by 12
Associations of frailty with survival, hospitalization, functional decline, and toxicity among older adults with advanced non-small cell lung cancer
Lee, H. J., Boscardin, W. J., Walter, L. C., Smith, A. K., Cohen, H. J., Giri, S., Williams, G. R., Presley, C. J., Singhal, S., Huang, L., et al. (2024) · The Oncologist · doi:10.1093/oncolo/oyae349 · Cited by 12
Colon cancer treatment and adherence to national guidelines: Does age still matter?
Jonker, J. M., Hamaker, M. E., Soesan, M., Tulner, C. R., & Kuper, I. M. J. A. (2012) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2011.12.003 · Cited by 13
The Treatment of Advanced Lung Cancer in the Elderly
Presley, C. J., & Lilenbaum, R. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000145 · Cited by 12
Early chemotherapy discontinuation and mortality in older patients with metastatic bladder cancer: The AGEVIM multicenter cohort study
Laurent, M., Brureau, L., Demery, M. E., Fléchon, A., Thuaut, A. L., Carvahlo-Verlinde, M., Bastuji‐Garin, S., Paillaud, É., Canouï‐Poitrine, F., & Culine, S. (2016) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2016.08.003 · Cited by 12
The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients
Racioppi, M., Gianfrancesco, L. D., Ragonese, M., Palermo, G., Sacco, E., & Bassi, P. (2018) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2018.03.020 · Cited by 12
Hospitalization and definitive radiotherapy in lung cancer: incidence, risk factors and survival impact
Hazell, S. Z., Mai, N., Fu, W., Hu, C., Friedes, C., Negron, A., Voong, K. R., Feliciano, J. L., Han, P., Myers, S., et al. (2020) · BMC Cancer · doi:10.1186/s12885-020-06843-z · Cited by 12
Circumstances around falls in older adults with Cancer
Tomczak, U., Sattar, S., Schoenbeck, K. L., Cordner, T., & Wildes, T. M. (2020) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2020.06.001 · Cited by 12
Prevalence and Predictive Factors for Upfront Dose Reduction of the First Cycle of First-Line Chemotherapy in Older Adults with Metastatic Solid Cancer: Korean Cancer Study Group (KCSG) Multicenter Study
Hwang, I. G., Kwon, M., Kim, J. W., Kim, S. H., Lee, Y., Kim, J. Y., Koh, S., Ko, Y. H., Shin, S. H., Hong, S., et al. (2021) · Cancers · doi:10.3390/cancers13020331 · Cited by 12
An evaluation of the Index4 tool for chemotherapy toxicity prediction in cancer patients older than 70 years old
Lewis, A., Reed, M., Walde, N., & Voutsadakis, I. A. (2023) · Scientific Reports · doi:10.1038/s41598-023-28309-5 · Cited by 12
Fixing the Leaky Pipe: How to Improve the Uptake of Patient-Reported Outcomes–Based Prognostic and Predictive Models in Cancer Clinical Practice
Spencer, K. L., Absolom, K. L., Allsop, M. J., Relton, S. D., Pearce, J., Liao, K., Naseer, S., Salako, O., Howdon, D., Hewison, J., et al. (2023) · JCO Clinical Cancer Informatics · doi:10.1200/cci.23.00070 · Cited by 13
Vejez y cáncer de mama, el desafío del siglo 21
Sanchez, C. G. (2012) · Revista médica de Chile · doi:10.4067/s0034-98872012000500015 · Cited by 12
Older patients/older donors: choosing wisely
Artz, A. S. (2013) · Hematology · doi:10.1182/asheducation-2013.1.70 · Cited by 12
Predictors of Unplanned Hospitalizations in Patients With Nonmetastatic Lung Cancer During Chemotherapy
Fessele, K. L., Hayat, M. J., & Atkins, R. L. (2017) · Oncology nursing forum · doi:10.1188/17.onf.e203-e212 · Cited by 12
Ground glass pulmonary nodules: their significance in oncology patients and the role of computer tomography and 18F–fluorodeoxyglucose positron emission tomography
Evangelista, L., Panunzio, A., Scagliori, E., & Sartori, P. (2018) · European Journal of Hybrid Imaging · doi:10.1186/s41824-017-0021-z · Cited by 12
Estimating survival time in older adults receiving chemotherapy for advanced cancer
Moth, E. B., Blinman, P. L., Stefanic, N., Naganathan, V., Grimison, P., Stockler, M. R., Beale, P. J., Martin, A. J., & Kiely, B. E. (2019) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2019.08.013 · Cited by 12
Current approaches to measuring functional status among older adults in VA primary care clinics.
Spar, M. J., Nicosia, F. M., Steinman, M. A., & Brown, R. T. (2017) · Europe PMC (PubMed Central) · Cited by 12
Short-Course Radiotherapy in Locally Advanced Rectal Cancer
Cambray, M., González-Viguera, J., Berenguer, M. Á., Macià, M., Losa, F., Soler, G., Frago, R., Castellví, J., & Guinó, E. (2020) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000162 · Cited by 12
Contemporary management of pancreas cancer in older people
Baltatzis, M., Rodriquenz, M. G., Siriwardena, A. K., & Carino, N. D. L. (2020) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2020.08.007 · Cited by 12
A Cost–Utility Analysis of Atezolizumab in the Second-Line Treatment of Patients with Metastatic Bladder Cancer
Parmar, A., Richardson, M., Coyte, P. C., Cheng, S. Y.-S., Sander, B., & Chan, K. (2020) · Current Oncology · doi:10.3747/co.27.5459 · Cited by 12
Chemotherapy and Targeted Agents in the Treatment of Elderly Patients with Metastatic Colorectal Cancer
Tuca, A., Gallego, R., Ghanem, I., Gil-Raga, M., & Feliú, J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9124015 · Cited by 12
Our experience of nursing/allied health practitioner led geriatric screening and assessment of older patients with cancer – a highly accessible model of care
Thaker, D. A., McGuire, P., Bryant, G., Wyld, D., Leach, J., Wheatley, H., Snape-Jenkinson, S. L., Kelly, B., Bourke, A., & Kennedy, G. (2021) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2021.05.003 · Cited by 12
Use of Comprehensive Geriatric Assessment in Oncology Patients to Guide Treatment Decisions and Predict Chemotherapy Toxicity
Tarchand, G. (2021) · Federal Practitioner · doi:10.12788/fp.0128 · Cited by 12
A mortality risk prediction model for older adults with lymph node-positive colon cancer
Jorgensen, M. L., Young, J. M., Dobbins, T., & Solomon, M. J. (2015) · European Journal of Cancer Care · doi:10.1111/ecc.12288 · Cited by 12
A call for observational cohort studies in geriatric oncology
Mohile, S. G., & Wildiers, H. P. M. W. (2012) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2012.04.006 · Cited by 12
Self-citation
Doublet Chemotherapy in the Elderly Patient With Ovarian Cancer
Teo, M. Y., Power, D. G., Tew, W. P., & Lichtman, S. M. (2012) · The Oncologist · doi:10.1634/theoncologist.2012-0155 · Cited by 12
Self-citation
Cáncer colorrectal en el anciano. Tratamiento quirúrgico, quimioterápico y aportación desde la geriatría
Sáez-López, P., Vegas, E. F., Martínez-Peromingo, F. J., & Mola, S. J. (2017) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2016.10.002 · Cited by 12
Clinical tools for chemotherapy toxicity prediction and survival in geriatric cancer patients
Voutsadakis, I. A. (2018) · Journal of Chemotherapy · doi:10.1080/1120009x.2018.1475442 · Cited by 12
Fighting diagnostic and therapeutic nihilism in the elderly with cancer
Biskup, E. M., Vetter, M. H. F., & Wedding, U. (2019) · Annals of Palliative Medicine · doi:10.21037/apm.2019.08.03 · Cited by 13
Predicting the Risks of Aggressive-Intent Chemotherapy Toxicity in Older Patients With Lymphoma: A Prospective Observational Pilot Study
Dhir, V., Maganti, M. D., Rozenberg, D., Kukreti, V., Kuruvilla, J. G., Crump, M., & Prica, A. A. (2022) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2022.04.011 · Cited by 11
Ototoxicity prognostic models in adult and pediatric cancer patients: a rapid review
Debacker, J. R., McMillan, G. P., Martchenke, N., Lacey, C., Stuehm, H. R., Hungerford, M. E., & Konrad‐Martin, D. (2023) · Journal of Cancer Survivorship · doi:10.1007/s11764-022-01315-8 · Cited by 12
Geriatric evaluation methods in oncology and their use in clinical studies: A systematic literature review
Stueger, A., Joerger, M., & Nys, K. D. (2023) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2023.101684 · Cited by 11
Implementation of a geriatric oncology service at the Royal Marsden Hospital
Eochagáin, C. M., Barrell, A., Slavova-Boneva, V., Murphy, J. M., Pattwell, M., Cumming, J., Edmondson, A., McGinn, M., Kipps, E., Milton, M., et al. (2024) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2023.101698 · Cited by 11
Effect of resistance training on physical function during chemotherapy in colon cancer
Brown, J. C., Yang, S., Compton, S. L. E., Campbell, K. L., Feliciano, E. M. C., Quinney, S. K., Sternfeld, B., Caan, B. J., Meyerhardt, J. A., & Schmitz, K. H. (2024) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkae058 · Cited by 14
Treatment strategies for elderly patients with locally advanced esophageal cancer: a systematic review and meta-analysis
Yao, J., Zhao, X., Chen, J., Liu, T., Song, Y., & Dang, J. (2024) · BMC Cancer · doi:10.1186/s12885-024-12853-y · Cited by 11
The Use of Artificial Intelligence in Predicting Chemotherapy-Induced Toxicities in Metastatic Colorectal Cancer: A Data-Driven Approach for Personalized Oncology
Froicu, E.-M., Oniciuc, O.-M., Afrăsânie, V.-A., Marinca, M. V., Riondino, S., Dumitrescu, E. A., Alexa‐Stratulat, T., Radu, I., Miron, L., Bacoanu, G., et al. (2024) · Diagnostics · doi:10.3390/diagnostics14182074 · Cited by 14
Treatment of Acute Myeloid Leukemia in Elderly Patients—A Therapeutic Dilemma
Mamdani, H. M., Santos, C. D., & Koenig, H. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.03.001 · Cited by 11
Controversial issues in the management of older adults with early breast cancer
Mislang, A. R., Cheung, K., Hamaker, M. E., Kunkler, I. H., Markopoulos, C. J., Orecchia, R., Brain, E. G. C., & Biganzoli, L. (2017) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2017.05.004 · Cited by 11
Safety and efficacy of preoperative chemoradiotherapy in fit older patients with intermediate or locally advanced rectal cancer evaluated by comprehensive geriatric assessment: A planned interim analysis of a multicenter, phase II trial
Liu, W., Jin, J., Tang, Y., Li, N., Tang, Y., Wang, J., Cheng, Y., Yang, L., Fang, H., Lu, N.-N., et al. (2020) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2020.10.016 · Cited by 10
Treatment Paradigms for Older Adults with Pancreatic Cancer: a Nuanced Approach
Winer, A., & Dotan, E. (2021) · Current Treatment Options in Oncology · doi:10.1007/s11864-021-00892-7 · Cited by 11
Survival benefit of chemotherapy in a contemporary cohort of metastatic urachal carcinoma
Flammia, R. S., Chierigo, F., Würnschimmel, C., Horlemann, B., Hoeh, B., Sorce, G., Tian, Z., Leonardo, C., Derya Tilki, A., Terrone, C., et al. (2021) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2021.09.008 · Cited by 11
Diversity, Equity, and Inclusion in Clinical Trials
Keegan, G., Crown, A., & Joseph, K.-A. P. (2022) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2022.08.005 · Cited by 11
Implementation and evaluation of a remote geriatric assessment and intervention program in Brazil
Bergerot, C. D., Bergerot, P. G., Razavi, M., Philip, E. J., Lakhdari, S., França, M. V. D. S., Molina, L. N. M., Freitas, A. N. D. S., Taveira, M. C., de Azeredo, A. C., et al. (2023) · Cancer · doi:10.1002/cncr.34759 · Cited by 11
Geriatric Oncology and Clinical Trials
Lichtman, S. M. (2015) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2015.35.e127 · Cited by 11
Self-citation
Aging and Cancer – Addressing a Nation’s Challenge
Bréchot, J.-M., Quellec-Nathan, M. L., & Buzyn, A. (2013) · Interdisciplinary topics in gerontology and geriatrics · doi:10.1159/000343575 · Cited by 11
From Shelf to Bedside—Wearable Electronic Activity Monitoring Technologies Might Assist Oncologists in Functional Performance Status Assessment of Older Cancer Patients
Kelly, C. M., & Shahrokni, A. (2016) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2016.11.002 · Cited by 11
Phase II study of dose-attenuated bortezomib, cyclophosphamide and dexamethasone (“VCD-Lite”) in very old or otherwise toxicity-vulnerable adults with newly diagnosed multiple myeloma
Tuchman, S. A., Moore, J. O., Decastro, C., Li, Z., Sellars, E., Kang, Y., Long, G. D., & Gasparetto, C. (2017) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2017.02.004 · Cited by 11
Access to information and counselling – older cancer patients’ self-report: a cross-sectional survey
Guldhav, K. V., Jepsen, R., Ytrehus, S., & Grov, E. K. (2017) · BMC Nursing · doi:10.1186/s12912-017-0211-9 · Cited by 11
Impact of Age, Comorbidity, and FIGO Stage on Treatment Choice and Mortality in Older Danish Patients with Gynecological Cancer: A Retrospective Register-Based Cohort Study
Nadaraja, S., Jørgensen, T. L., Matzen, L.-E., & Herrstedt, J. (2018) · Drugs - Real World Outcomes · doi:10.1007/s40801-018-0145-x · Cited by 11
Oncologists' perceptions on the usefulness of geriatric assessment measures and the CARG toxicity score when prescribing chemotherapy for older patients with cancer
Moth, E. B., Kiely, B. E., Stefanic, N., Naganathan, V., Martin, A. J., Grimison, P., Stockler, M. R., Beale, P. J., & Blinman, P. L. (2018) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2018.11.004 · Cited by 11
Association of multidimensional comorbidities with survival, toxicity, and unplanned hospitalizations in older adults with metastatic colorectal cancer treated with chemotherapy
Kim, K. H., Lee, J. J., Kim, J., Zhou, J., Gomes, F., Sehovic, M., & Extermann, M. (2019) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2019.02.003 · Cited by 11
Ready for prime time: role for geriatric assessment to improve quality of care in hematology practice
Klepin, H. D. (2019) · Hematology · doi:10.1182/hematology.2019001299 · Cited by 11
Self-citation
Pharmacokinetic and pharmacodynamic analysis of neutropenia following nab-paclitaxel administration in Japanese patients with metastatic solid cancer
Tsushima, T., Kasai, H., & Tanigawara, Y. (2020) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-020-04140-x · Cited by 11
Clinical outcomes associated with anticholinergic burden in older hospitalized patients with advanced cancer: a single-center database study
Lee, J. H., Lim, J. R. N., Han, S. J., do Moon, S., Moon, H., Lee, S.-Y., Kim, H., & Jung, H.-W. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-021-06008-z · Cited by 11
Age-related Differences in Recall of Information and Handling of Chemotherapy-related Side Effects in Cancer Patients: The ReCap Study
Lund, C. M., Mikkelsen, M. K., Theile, S., Michelsen, H. M., Schultz, M., Sengeløv, L., & Nielsen, D. L. (2022) · The Oncologist · doi:10.1093/oncolo/oyab034 · Cited by 11
Major clinical benefit from adjuvant chemotherapy for stage II–III non-small cell lung cancer patients aged 75 years or older: a propensity score-matched analysis
Blasi, M., Eichhorn, M., Christopoulos, P., Winter, H., Heußel, C. P., Herth, F. J. F., Shafie, R. A. E., Kriegsmann, K., Kriegsmann, M., Stenzinger, A., et al. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-022-02043-6 · Cited by 11
Geriatric assessment in the older adult with genitourinary cancer: A narrative review
Singhal, S., Marwell, J. G., & Khaki, A. R. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1124309 · Cited by 12
Current Approaches to the Management of Bladder Cancer in Older Patients
Stensland, K. D., & Galsky, M. D. (2014) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2014.34.e250 · Cited by 11
Geriatric assessment of older patients with cancer in Australia—A multicentre audit
Lakhanpal, R., Yoong, J., Joshi, S., Yip, D., Mileshkin, L., Marx, G. M., Dunlop, T., Hovey, E. J., Della‐Fiorentina, S. A., Venkateswaran, L., et al. (2015) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2015.03.001 · Cited by 11
Palliative chemotherapy for gastroesophageal cancer in old and very old patients: A retrospective cohort study at the National Center for Tumor Diseases, Heidelberg
Berger, A. K. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i16.4911 · Cited by 11
The use of wearable technology in studies in older adults with cancer: a systematic review
Duin, J. J., Baltussen, J. C., Albalak, G., van Dam van Isselt, E. F., Portielje, J. E. A., Mooijaart, S. P., Soto-Perez-de-Celis, E., & van den Bos, F. (2025) · The Oncologist · doi:10.1093/oncolo/oyae319 · Cited by 11
Predictive model of chemotherapy-related toxicity in elderly Chinese cancer patients
Hua, Y., Zou, Y., Guan, M., Yuan, H., Zhou, Y., & Liu, F. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1158421 · Cited by 10
Systematic nutritional screening and assessment in older patients: Rationale for its integration into oncology practice
Bauer, J. M., Pattwell, M., Barazzoni, R., Battisti, N. M. L., Soto‐Pérez‐de‐Celis, E., Hamaker, M. E., Scotté, F., Soubeyran, P., & Aapro, M. (2024) · European Journal of Cancer · doi:10.1016/j.ejca.2024.114237 · Cited by 10
The Edmonton Frail Scale as a screening score for frailty in oncogeriatrics
Schrevel, J. D., Faucon, C., Sibille, F., Dumont, L., Herrmann, F. R., Rouvière, H., & Breucker, S. D. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1466366 · Cited by 10
The impact of frailty on chemotherapy intolerance in patients with cervical cancer: A longitudinal study
Wang, Y., Zhang, Y., Liang, X., Liu, J. H., Zhao, Y., & Su, Q. (2024) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2024.102725 · Cited by 10
Intensive Chemotherapy Versus Venetoclax-Based Regimens in Elderly Patients with Acute Myeloid Leukemia: Is the Chemotherapy Era Ending?
Farina, M., Malagola, M., Bernardi, S., Re, F., Russo, D., & Avenoso, D. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14082759 · Cited by 10
How I treat ovarian cancer in older women
Lichtman, S. M. (2014) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2014.06.001 · Cited by 10
Self-citation
Meta-analysis examining impact of age on overall survival with pemetrexed for the treatment of advanced non-squamous non-small cell lung cancer
Paz-Ares, L. G., Zimmermann, A. H., Ciuleanu, T., Bunn, P. A., Antonio, B. S., Denne, J. S., Iturria, N. L., John, W. J., & Scagliotti, G. V. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.12.007 · Cited by 10
From clinical trials to real-world practice: Immune checkpoint inhibitors in older adults
Loh, K. P., Wong, M. L., & Maggiore, R. J. (2019) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2019.01.023 · Cited by 10
Outcomes in patients ≥ 80 years with a diagnosis of a hepatopancreaticobiliary (HPB) malignancy
Lewis, A. R., Cipriano, C., Wang, X., Ward, R., Fitzpatrick, A., Scott, A. R. M., Rashed, A., Raja, H., Lamarca, Á., Hubner, R. A., et al. (2019) · Medical Oncology · doi:10.1007/s12032-019-1310-0 · Cited by 10
Prevalence of comorbidity in cancer patients scheduled for systemic anticancer treatment in Austria
Balić, M., Hilbe, W., Gusel, S., Fiegl, M., Ludwig, H., Mayrbäurl, B., Thaler, J., Samonigg, H., Hegenbarth, K., Eisner, F., et al. (2019) · memo - Magazine of European Medical Oncology · doi:10.1007/s12254-019-00542-7 · Cited by 10
Tinagl1 Gene Therapy Suppresses Growth and Remodels the Microenvironment of Triple Negative Breast Cancer
Musetti, S., & Huang, L. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00008 · Cited by 10
Impacto del envejecimiento sobre la incidencia y mortalidad de los cánceres urológicos: proyección a 20 años en España
Gómez-Palomo, F., Sánchez-González, J. V., Gómez, A. B. G., Ardavín, J. P., & Cerdá, J. L. R. (2022) · Actas Urológicas Españolas · doi:10.1016/j.acuro.2021.10.001 · Cited by 10
Age and comorbidity association with survival outcomes in metastatic colorectal cancer: CALGB 80405 analysis
McCleary, N. J., Zhang, S., Ma, C., Ou, F., Bainter, T. M., Venook, A. P., Niedzwiecki, D., Lenz, H., Innocenti, F., O’Neil, B. H., et al. (2022) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2022.01.006 · Cited by 10
Predictors of three-month mortality and severe chemotherapy-related adverse events in patients aged 70 years and older with metastatic non-small-cell lung cancer: A secondary analysis of ESOGIA-GFPC-GECP 08–02 study
Gendarme, S., Zebachi, S., Corre, R., Greillier, L., Justeau, G., Bylicki, O., Decroisette, C., Auliac, J. B., Guisier, F., Geier, M., et al. (2023) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2023.101506 · Cited by 10
Racial Differences in Aging-Related Deficits Among Older Adults With Colorectal Cancer
Smithson, M. G., McLeod, M. C., Al‐Obaidi, M., Harmon, C. A., Sawant, A. R., Hardiman, K. M., Chu, D. I., Bhatia, S., Williams, G. R., & Hollis, R. H. (2023) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000002672 · Cited by 10
Self-citation
Evidence-Based Care of Older Adults With Metastatic Colorectal Cancer: Insights From Landmark Clinical Trials
Ioffe, D., & Dotan, E. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.01337 · Cited by 10
Determining the relationship of p16INK4a and additional molecular markers of aging with clinical frailty in hematologic malignancy
Rosko, A. E., Elsaid, M. I., Woyach, J. A., Islam, N., Lepola, N., Urrutia, J. M., Christian, L. M., Presley, C. J., Mims, A. S., & Burd, C. E. (2024) · Journal of Cancer Survivorship · doi:10.1007/s11764-024-01591-6 · Cited by 10
Diffuse large B-cell non-Hodgkin lymphoma in the very elderly: challenges and solutions.
Latta, S., Cygan, P. H., Fried, W., & Nabhan, C. (2013) · PubMed · Cited by 10
Current and Emerging Options in the Management of EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Considerations in the Elderly
Minuti, G., D’Incecco, A., & Cappuzzo, F. (2015) · Drugs & Aging · doi:10.1007/s40266-015-0305-6 · Cited by 10
From suboptimal to optimal treatment in older patients with cancer
Soubeyran, P. (2013) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2013.04.007 · Cited by 10
The risk of second malignancies after 125I prostate brachytherapy as monotherapy in a single Australian institution
Ots, A., Browne, L. H., Chin, Y. S., Malouf, D. J., WONG, K. K. H., & Bucci, J. A. (2016) · Brachytherapy · doi:10.1016/j.brachy.2016.06.005 · Cited by 10
Incorporating Geriatric Medicine Providers into the Care of the Older Adult with Cancer
Magnuson, A. M., Canin, B. E., Londen, G. J. V., Edwards, B. J.-A., Bakalarski, P., & Parker, I. R. (2016) · Current Oncology Reports · doi:10.1007/s11912-016-0550-9 · Cited by 9
Survival benefit evaluation of radiotherapy in esophageal cancer patients aged 80 and older
Huang, S. H., Zheng, S., Gong, T., Ma, H., Ke, Y., Zhao, S., Wang, W., Jia, L., & Zhang, X. (2017) · Oncotarget · doi:10.18632/oncotarget.22884 · Cited by 10
Understanding fall risk for older adults with cancer: An evaluation of experts' perceptions
Covington, K. R., Atler, K. E., Schmid, A. A., & Pergolotti, M. (2019) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2019.06.006 · Cited by 10
Bortezomib in first-line therapy is associated with falls in older adults with multiple myeloma
Schoenbeck, K. L., Fiala, M. A., & Wildes, T. M. (2021) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2021.02.009 · Cited by 10
Real‑world challenge for clinicians treating advanced gastroesophageal adenocarcinoma (Review)
Baxter, M. A., Petty, R., Swinson, D., Hall, P. S., & O’Hanlon, S. (2021) · International Journal of Oncology · doi:10.3892/ijo.2021.5202 · Cited by 10
Clinical characteristics and survival of colorectal cancer patients in Korea stratified by age
Baek, S. K., Lee, J. S., Hwang, I. G., Kim, J. G., Kim, T. W., Sohn, S. K., Kang, M. Y., & Lee, S. (2021) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2019.066 · Cited by 10
Health-related quality of life in older patients with HER2+ metastatic breast cancer: Comparing pertuzumab plus trastuzumab with or without metronomic chemotherapy in a randomised open-label phase II clinical trial
Lago, L. D., Uwimana, A. L., Coens, C., Vuylsteke, P., Curigliano, G., Brouwers, B. A. H., Jagiełło-Gruszfeld, A., Altıntaş, S., Tryfonidis, K., Poncet, C., et al. (2022) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2022.01.009 · Cited by 10
Piloting HealthScore : Feasibility and acceptability of a clinically integrated health coaching program for people living with cancer
Wood, W. A., Bailey, C., Castrogivanni, B., Mehedint, D., Bryant, A. L., Lavin, K. N., Tan, X. M., Richardson, J., Qian, Y., Tan, K., et al. (2023) · Cancer Medicine · doi:10.1002/cam4.5625 · Cited by 9
Approach to the Older Patient with Stage II/III Colorectal Cancer: Who Should Get Curative-Intent Therapy?
Ramsdale, E. E., Sanoff, H. K., & Muss, H. B. (2013) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbook_am.2013.33.163 · Cited by 10
Update on the Management of Pancreatic Cancer in Older Adults
Lee, S. Y., Sissoko, M., & Hartshorn, K. L. (2016) · Current Oncology Reports · doi:10.1007/s11912-016-0547-4 · Cited by 10
Feasibility of dose-dense paclitaxel/carboplatin therapy in elderly patients with ovarian, fallopian tube, or peritoneal cancer
Bun, S., Yunokawa, M., Ebata, T., Shimomura, A., Shimoi, T., Kodaira, M., Yonemori, K., Shimizu, C., Fujiwara, Y., Kato, T., et al. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-016-3100-0 · Cited by 10
Drug prescription including interactions with anticancer treatments in the elderly: A global approach
Bugat, M.-È. R., Bourgouin, M., Gérard, S., Lozano, S., Bréchemier, D., Cestac, P., Cool, C., & Balardy, L. (2017) · The journal of nutrition health & aging · doi:10.1007/s12603-017-0946-8 · Cited by 10
The association of age with acute toxicities in NRG oncology combined modality lower GI cancer trials
VanderWalde, N. A., Moughan, J., Lichtman, S. M., Jagsi, R., Ballo, M. T., Vanderwalde, A. M., Mohiuddin, M., Meropol, N. J., Kachnic, L. A., Berger, A. C., et al. (2021) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2021.10.008 · Cited by 10
Self-citation
Special Issues in Older Women with Breast Cancer
Hurria, A., & Muss, H. B. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-16366-6_3 · Cited by 10
Self-citation
Clinical factors associated with the therapeutic outcome of chemotherapy in very elderly cancer patients
Ito, S., Ito, H., Sato, N., Hirayama, Y., Kusakabe, T., Terui, T., & Ishitani, K. (2019) · International Journal of Clinical Oncology · doi:10.1007/s10147-018-01385-8 · Cited by 10

Authors: Hurria, A., Togawa, K., Mohile, S. G., Owusu, C., Klepin, H. D., Gross, C. P., Lichtman, S. M., Gajra, A., Bhatia, S., Katheria, V., Klapper, S., Hansen, K., Ramani, R., Lachs, M., Wong, F. L., & Tew, W. P.
Affiliations: City Of Hope National Medical Center (US)
Arti Hurria, Kayo Togawa, Smita Bhatia, Rupal Ramani, and F. Lennie Wong, City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte; Kurt Hansen, University of California Davis School of Medicine, Sacramento, CA; Supriya G. Mohile, University of Rochester Medical Center, Rochester; Stuart M. Lichtman, Shira Klapper, and William P. Tew, Memorial Sloan-Kettering Cancer Center; Mark Lachs, Weill Cornell Medical College, New York; Ajeet Gajra, State University of New York Upstate...
ORCID: Hurria, Arti
Togawa, Kayo
Mohile, Supriya G.
Owusu, Cynthia
Klepin, Heidi D.
Gross, Cary P.
Lichtman, Stuart M.
Gajra, Ajeet
Katheria, Vani
Lachs, Mark
Wong, F. Lennie
Tew, William P.
Venue: Journal of Clinical Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Published: 2011-09-01
Volume: 29
Issue: 25
Pages: 3457-3465
ISSN: 0732-183X (ISSN-L)
1527-7755
DOI: 10.1200/jco.2011.34.7625
PMC: PMC3624700
OpenAlex: W2153294383
Cited by: 1,841
References: 43
Citations by year: 2026: 98 · 2025: 98 · 2024: 117 · 2023: 119 · 2022: 153 · 2021: 149 · 2020: 148 · 2019: 147 · 2018: 143 · 2017: 129 · 2016: 134 · 2015: 114 · 2014: 112 · 2013: 87 · 2012: 73
FWCI: 43.61
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Oncology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Amgen
GlaxoSmithKline
American Society of Clinical Oncology
Celgene
Genentech
National Institute on Aging (K24AG022399, 1K08 AG 24842, K08AG024842, K23AG038361, K23AG026749)
National Cancer Institute (U10CA098543)
Topics: Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords: chemotherapy toxicity, older adults, geriatric assessment, risk stratification, risk prediction model, comorbidities, functional status, nutritional status, cognitive status, laboratory parameters, geriatric oncology
MeSH terms: Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Neoplasms, Predictive Value of Tests, Prospective Studies, Comorbidity, Survival Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks